Search Results 1231-1240 of 19369 for hemoglobin

1. A Study to Evaluate Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration In HPV Head And Neck Cancer - Mayo Clinic

   Hemoglobin ≥8.0g/dL;; Creatinine ≤ 1.5 mg/dL or creatinine clearance ≥ 50 mL/min;; Total or direct bilirubin < 2 x institutional upper limit of normal (ULN); ...

2. A Study of Minimally Invasive Pericardiotomy as a New Treatment for Heart Failure - Mayo Clinic

   Any hemoglobin (Hgb) < 8.0 g/dl within 30 days prior to randomization. Any GFR < 20 ml/min/1.73 m2 within 30 days prior to randomization. Significant ...

3. A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM) (KarMMa-4) - Mayo Clinic

   Participation eligibility · Absolute neutrophil count < 1,000/μL; · Platelet count < 50,000 mm^3; · Hemoglobin < 8 g/dL (< 4.9 mmol/L); · Serum creatinine clearance ...

4. S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer - Mayo Clinic

   Hemoglobin ≥ 9 g/dL. Platelet count ≥ 100,000/mL. Bilirubin ≤ 1.5 mg/dL ... Patients previously diagnosed with diabetes must not have uncontrolled diabetes ( ...

5. Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET - Mayo Clinic

   * Hemoglobin (Hb) ≥ 8 g/dL * Creatinine clearance \> 40 mL/min calculated by the Cockcroft Gault method * Total bilirubin ≤ 3 x ULN * Potassium within ...

6. Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement - Mayo Clinic

   Subject has (hemoglobin) Hgb <9 g/dL, platelet count <50,000 cells/mm3 or >700,000 cells/mm3, or white blood cell count <1,000 cells/mm3. Subject requires ...

7. Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

   You have a neutrophil count (type of white blood cell) less than 1500/mm3, platelet count less than 50,000/mm3, or a hemoglobin less than 7 g/dL; You have an ...

8. Study Of GI-102 And PD-1 In Glioblastoma - Mayo Clinic

   Participation eligibility · Hemoglobin ≥9.0 g/dL · Absolute neutrophil count (ANC) ≥1500/mm3 · Platelet count ≥100,000/mm3 · Creatinine ≤1.5 x ULN OR measured ...

9. Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy - Mayo Clinic

   -Hemoglobin >= 7.0 g/dL if asymptomatic or hemoglobin > 8 if symptomatic; transfusion support allowed, if necessary (obtained =< 14 days prior to registration).

10. Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression - Mayo Clinic

    hemoglobin greater than or equal to 9 g/dl;; aspartate aminotransferase (AST) and alanine aminotransferase (ALT) less than 3 times the upper limit of normal ...